1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Guidance for Industry, https://www.fda.gov/media/123448/download; 2020 Accessed July 01, 2021.
2. The American Red Cross. Approach to Platelet Safety: Implementation Plan for Bacterial Control Strategies 2020, https://www.redcrossblood.org/content/dam/redcrossblood/hospital-page-documents/red_cross_approach_to_platelet_safety__rcb__july_15_2020.pdf; Accessed July 01, 2021.
3. Financial analysis of large-volume delayed sampling to reduce bacterial contamination of platelets;Kacker;Transfus,2020
4. Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions;Kacker;Transfus,2019
5. A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States;Kleinman;Transfus,2013